PMID- 15800052 OWN - NLM STAT- MEDLINE DCOM- 20050811 LR - 20220225 IS - 0363-6143 (Print) IS - 0363-6143 (Linking) VI - 289 IP - 2 DP - 2005 Aug TI - Changes in intracellular Ca2+ and pH in response to thapsigargin in human glioblastoma cells and normal astrocytes. PG - C361-71 AB - Despite extensive work in the field of glioblastoma research no significant increase in survival rates for this devastating disease has been achieved. It is known that disturbance of intracellular Ca(2+) ([Ca(2+)](i)) and intracellular pH (pH(i)) regulation could be involved in tumor formation. The sarco(endo)plasmic reticulum Ca(2+)-ATPase (SERCA) is a major regulator of [Ca(2+)](i). We have investigated the effect of inhibition of SERCA by thapsigargin (TG) on [Ca(2+)](i) and pH(i) in human primary glioblastoma multiforme (GBM) cells and GBM cell lines, compared with normal human astrocytes, using the fluorescent indicators fura-2 and BCECF, respectively. Basal [Ca(2+)](i) was higher in SK-MG-1 and U87 MG but not in human primary GBM cells compared with normal astrocytes. However, in tumor cells, TG evoked a much larger and faster [Ca(2+)](i) increase than in normal astrocytes. This increase was prevented in nominally Ca(2+)-free buffer and by 2-APB, an inhibitor of store-operated Ca(2+) channels. In addition, TG-activated Ca(2+) influx, which was sensitive to 2-APB, was higher in all tumor cell lines and primary GBM cells compared with normal astrocytes. The pH(i) was also elevated in tumor cells compared with normal astrocytes. TG caused acidification of both normal and all GBM cells, but in the tumor cells, this acidification was followed by an amiloride- and 5-(N,N-hexamethylene)-amiloride-sensitive recovery, indicating involvement of a Na(+)/H(+) exchanger. In summary, inhibition of SERCA function revealed a significant divergence in intracellular Ca(2+) homeostasis and pH regulation in tumor cells compared with normal human astrocytes. FAU - Kovacs, Gergely Gy AU - Kovacs GG AD - Department of Physiology and Biophysics, University of Alabama at Birmingham, Birmingham, AL 35294, USA. FAU - Zsembery, Akos AU - Zsembery A FAU - Anderson, Susan J AU - Anderson SJ FAU - Komlosi, Peter AU - Komlosi P FAU - Gillespie, G Yancey AU - Gillespie GY FAU - Bell, P Darwin AU - Bell PD FAU - Benos, Dale J AU - Benos DJ FAU - Fuller, Catherine M AU - Fuller CM LA - eng GR - CA-101952/CA/NCI NIH HHS/United States GR - DK-3202/DK/NIDDK NIH HHS/United States GR - P50CA97247/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. DEP - 20050330 PL - United States TA - Am J Physiol Cell Physiol JT - American journal of physiology. Cell physiology JID - 100901225 RN - 0 (Calcium Channels) RN - 0 (Enzyme Inhibitors) RN - 67526-95-8 (Thapsigargin) RN - EC 3.6.3.8 (Sarcoplasmic Reticulum Calcium-Transporting ATPases) RN - EC 7.2.2.10 (Calcium-Transporting ATPases) RN - SY7Q814VUP (Calcium) SB - IM MH - Astrocytes/drug effects/*metabolism MH - Calcium/*metabolism MH - Calcium Channels/drug effects/metabolism MH - Calcium-Transporting ATPases/antagonists & inhibitors MH - Cell Line, Tumor MH - Cell Proliferation/drug effects MH - Endoplasmic Reticulum/drug effects/metabolism MH - Enzyme Inhibitors/*pharmacology MH - Glioblastoma/*metabolism MH - Humans MH - Hydrogen-Ion Concentration/drug effects MH - Intracellular Fluid/chemistry MH - Sarcoplasmic Reticulum Calcium-Transporting ATPases MH - Thapsigargin/*pharmacology EDAT- 2005/04/01 09:00 MHDA- 2005/08/12 09:00 CRDT- 2005/04/01 09:00 PHST- 2005/04/01 09:00 [pubmed] PHST- 2005/08/12 09:00 [medline] PHST- 2005/04/01 09:00 [entrez] AID - 00280.2004 [pii] AID - 10.1152/ajpcell.00280.2004 [doi] PST - ppublish SO - Am J Physiol Cell Physiol. 2005 Aug;289(2):C361-71. doi: 10.1152/ajpcell.00280.2004. Epub 2005 Mar 30.